Profits rise at BluePoint Pharmaceuticals but Cork firm warns of impact of tariffs
but warned that 'geopolitical risks' could impact its operations.
Turnover at the Little Island firm grew to $218.66 million in the year ending September 2024, according to recently filed accounts with the Companies Registration Office.
Turnover grew by just less than $650,000 in 2024, but this came after a $38 million increase in turnover in 2023 to $218.01 million.
The company is ultimately owned by one of the largest pharmaceutical companies in the world, New York-listed Cencora Inc, formerly known as AmerisourceBergen Corporation. The parent company reported global turnover in 2024 of $294 billion.
READ MORE
With a US-based parent company, the company warned that
US import tariffs
post a risk to its operations noting the economic measures could affect its input costs or have 'adverse impacts' on demand for its products and supply chains.
The company's directors warned that, among other factors, the uncertainty around the impact of tariffs, market volatility and 'slower economic growth or recession' could impact the business in 2025.
Gross profits widened slightly in 2024 as costs of sales decreased but distribution and administrative expenses cut back pretax profits to within $50,000 of 2023. The company paid $1.83 million in tax in the financial year, compared with $1.94 million the year prior.
Post-tax profits grew from $12.232 million in 2023, to $12.379 million in 2024. HP Pharmaceuticals Unlimited paid a $25 million dividend to shareholders, having not proposed a dividend since it made a $17 million shareholder payout in 2022.
Staffing at the Cork business remained static at 36 in the period, though total payroll costs increased from $4.7 million in 2023, to $5.5 million in 2024, primarily driven by overall wages and salaries increasing by 17 per cent. Salary paid to directors stood at $513,000.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
17 minutes ago
- Irish Times
Keychain raises $30m in funding as it plans further expansion
AI powered supply chain platform Keychain, cofounded by Irish entrepreneur Oisin Hanrahan, has raised $30 million (€25.6 million) in funding as the company expands its product line and plans to grow its staff numbers. The Series B round was led by Wellington Management and existing investor BoxGroup, with other existing investors also taking part. The funding will support roll-out plans for the company's AI based operating system KeychainOS, which is designed to helps manufacturers manage their production cycle. The new product is taking on the established players in the system, Mr Hanrahan said, such as Oracle, Redzone, QAD and others. READ MORE 'This an AI enabled operating system for manufacturers to better run their facilities,' he said. 'They all have little bits of the product but no one has put it together into one unified system. We think it's going to build a better way for manufacturers to run their business. We think it will help them get product to market faster and take waste out of the system.' Keychain has raised a total of $68 million to date, 18 months after it first launched with its core product, which puts brands, retailers and manufacturers in touch with manufacturing partners, cutting out brokers and making the process more efficient and cost-effective. 'That product has a lot of room to expand,' Mr Hanrahan said. 'It's already expanded into packaging, into health, beauty and supplements. We are very excited about where it is going.' Mr Hanrahan said the company has significant cash on its balance sheet to support its expansion, with plans to double the size of its engineering team to around 70 people. It currently counts eight of the 10 top US retailers among its customers, with seven of the top 10 CPG brands, including General Mills also using the platform. 'Keychain has demonstrated a strong ability to bring new products to market quickly while scaling their operations effectively,' said Molly Breiner, sector lead for private climate investing at Wellington Management. 'Their approach addresses clear gaps in the CPG supply chain by offering a more streamlined and connected alternative to traditional ERP systems to create a more efficient, resilient, and connected ecosystem for manufacturers.'
Irish Times
17 minutes ago
- Irish Times
Leprino Foods plan to close Portlaoise plant threatens 130 jobs
Around 130 jobs could be lost after the Leprino Foods Company said it will close its manufacturing plant in Portlaoise in the second half of next year. The Co Laois factory produces mozzarella and string cheese. Siptu representatives are due to meet with senior management at Leprino Foods in Portlaoise on Wednesday. Terry Bryan, Siptu Industrial Organiser, on Tuesday said: 'Our immediate thoughts are with our members and their families following this shocking announcement this afternoon. READ MORE 'We have already been in contact with the company and have confirmed that we will meet with them tomorrow to discuss the full implications of the decision. 'We will engage with the company directly to see if we can lessen the impact of the decision upon our members and their families, and try to explore alternatives to the proposed job losses.' Mr Bryan said the company is 'a significant employer in the Portlaoise and midland area, employing 130 workers'. 'It has only been in operation since 2020 and is a modern, state-of-the-art facility. This is both a shocking and regrettable announcement,' he said in a statement. 'Siptu's focus and concern is for our members and our members' families at this difficult time.' Leprino employs around 5,500 people worldwide.
Irish Independent
an hour ago
- Irish Independent
Protesters call on Central Bank of Ireland not to renew approval of Israel Bond sales
Speaking at a protest, organised by the Ireland-Palestine Solidarity Campaign, outside the Central Bank in Dublin, David Landy of Jews for Palestine and Academics for Palestine calls on the bank not to renew approval for the sale of Israel Bonds.
